Fenza

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fenza

Quick Facts

Property Description
Active Ingredients Fenticonazole, plus 20+ vitamins, minerals, and Tuna Oil
Form Capsule (often Softgel), Vaginal Ovule
Pharmacological Class Azole Antifungal Agent and Multivitamin/Multimineral Supplement
Common Use (General) Dual action: Targeted antifungal relief and systemic nutritional support
Origin Synthetic (Fenticonazole) and Natural/Derived (Micronutrients)

Fenza is a specialized Combination Product that integrates a potent therapeutic drug, Fenticonazole, with an extensive complex of essential nutritional supplements in a singular formulation. This dual composition, which includes both the Azole Antifungal Agent and a comprehensive Multivitamin/Multimineral/Fatty Acid Supplement, makes Fenza distinct from standard single-ingredient drugs. Its design reflects a strategy to address targeted issues while offering general systemic support. This combined approach is clinically recognized for delivering both a localized effect and essential metabolic reinforcement.

What Type of Medicine is Fenza?

Fenza's classification is fundamentally driven by its fixed-dose inclusion of the synthetic compound Fenticonazole alongside a broad nutritional complex. Fenticonazole belongs to the class of imidazole derivatives, a type of Antifungal Agent that primarily works by inhibiting ergosterol biosynthesis, a key process for fungal cell membrane integrity. Azole Antifungals are recognized as a significant class of medicines for treating fungal infections. The product is typically presented as a capsule or vaginal ovule, allowing for either a systemic (oral) or topical (intravaginal) route of administration, depending on the therapeutic need.

Fenza Composition: Drug, Micronutrients, and Origin

The composition features the core drug, Fenticonazole, alongside a rich matrix of natural/derived micronutrients. The formula provides essential vitamins including the full B-group, Ascorbic Acid (Vit C), and Vit D3, as well as critical trace elements such as Iron (Fe), Calcium (Ca), and Zinc (Zn). This nutritional component is specifically formulated to support high metabolic demands, often including fatty acids sourced from Tuna Oil. This comprehensive nutritional profile differentiates the product significantly from generic antifungal formulations, which typically lack this systemic reinforcement element.

What side effects are possible with Fenza?

Possible Side Effects and Safety Information

The safety profile of Fenza, a combination of the antifungal Fenticonazole and a multivitamin/multimineral supplement, is defined by regulatory agencies based on effects related to both components.

Adverse reactions are classified by frequency and grouped into System-Organ Classes (SOC) as per official documentation.


Localized and Systemic Adverse Reactions

Classification Type of Reaction (Regulatory Terminology)
Very Rare (or equivalent) Vulvovaginal burning sensation, pruritus (itching), erythema (redness), and rash at the application site.
Frequency Not Known Application site hypersensitivity or sensitization.

Localized reactions such as the burning sensation are often described in regulatory documents as mild and transient, usually occurring shortly after application. Prolonged use carries a documented risk of developing local sensitization.


Safety Considerations and Constraints

High-level safety constraints govern the use of Fenza, derived directly from labeling:

  • Hypersensitivity: The medicine is contraindicated in individuals with known hypersensitivity to Fenticonazole, other imidazole derivatives, or any excipients.
  • Serious Risk: The multimineral component introduces a risk of Iron Overload Syndrome (e.g., in predisposed individuals with hemochromatosis), a serious concern that must be noted for systemic supplements containing high-dose Iron.
  • Latex Caution: The oily excipients contained in the formulation can potentially damage latex barrier contraceptives (such as condoms or diaphragms), a restriction explicitly mandated in official regulatory labeling.
  • Special Populations: Use during pregnancy and lactation requires specific guidance and supervision from a physician, and safety for the pediatric population is not fully established.

Overdose and Emergency Response

Overdose and When to Seek Help

The Fenza (Fenticonazole) formulation is intended for local, non-systemic application, which makes an overdose via the prescribed route highly unlikely. Regulatory information primarily addresses the risk associated with accidental oral ingestion of the product.


Documented Manifestations and Actions

Overdose Context Documented Manifestations
Accidental Oral Ingestion Abdominal pain, Vomiting

Required Emergency Response

The product is not for oral use. If accidental ingestion occurs, seeking medical advice is required due to the potential for gastrointestinal symptoms. Regulatory authorities mandate that a healthcare professional must be contacted immediately after the product has been swallowed, even if symptoms are not yet apparent.

Population-Specific Considerations

The potential for Fenticonazole and its metabolites to be excreted in breast milk has been noted in studies. Therefore, if accidental ingestion occurs while the individual is breast-feeding, a risk to the infant cannot be excluded, underscoring the necessity of seeking urgent medical guidance in this specific circumstance.

Therapeutic Uses of Fenza

What Fenza Treats: Main Uses and Benefits

Fenza is generally applied in situations involving certain distressing symptoms associated with certain conditions, primarily in the context of vulvovaginal candidiasis (yeast infection). This therapeutic domain is considered relevant across contexts marked by increased discomfort or tension.

It is used for managing conditions characterized by periods of heightened symptoms associated with acute or recurrent episodes. This medication helps address symptom clusters that may become intense or disruptive, such as those that create noticeable physiological strain, including itching, burning, and irritation. Fenza is commonly used during phases when symptoms become more noticeable, helping to address the discomfort.

The medication supports the patient during difficult episodes by easing distress and contributes to improved comfort during symptomatic periods. The use of Fenza may assist with maintaining functional stability and may contribute to reducing the impact of these symptoms on routine activities. This focus is on providing supportive relief when symptoms interfere with routine activities.

“The application is considered relevant when symptoms cluster and create noticeble functional strain.”

Quick Fact: Managing Symptoms Related to Localized Irritation

Eligibility and Restrictions for Use

Fenza (fenticonazole) is an antifungal medicine whose official regulatory documentation defines its user eligibility based on specific contraindications and restrictions.

Eligibility scope

Population Status Eligibility Classification (Official)
Known Hypersensitivity Contraindicated (Must Not Use)
Children / Pre-pubertal girls Not Recommended for Use
Pregnancy / Lactation Restricted / Only if essential

The medicine is contraindicated for any individual with a known hypersensitivity or allergy to the active substance, fenticonazole, or to any other ingredients in the product.

Restrictions and Special Considerations

Use is not recommended for populations defined by age, specifically children and pre-pubertal girls, as safety and efficacy have not been established in these groups.

For pregnant or lactating patients, use is restricted and advised only if a healthcare provider considers it essential to the patient’s welfare, due to limited experience with the medicine in these circumstances.

Additionally, for local vaginal formulations, it is officially documented that the medicine may damage latex contraceptives (such as condoms or diaphragms), requiring alternative contraceptive measures to be used during treatment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Fenza, as a hormonal contraceptive, has documented interactions that primarily affect its effectiveness through two mechanisms: enzyme induction and altered absorption.

Interacting Medicinal Product Category Practical Regulatory Implication
Hepatic Enzyme-Inducing Drugs (e.g., Rifampicin, Carbamazepine, St John's Wort) These drugs reduce the plasma concentrations of the contraceptive hormones. Official regulatory documents require the use of an alternative, unaffected contraceptive method, or the mandatory use of additional barrier contraception during treatment and for a specified time (commonly 28 days) after discontinuation. Progestogen-only pills are generally not recommended for use with potent enzyme inducers.
GLP-1 Agonists (e.g., Tirzepatide, Exenatide) These agents may reduce the rate and extent of absorption of oral medicines by delaying gastric emptying. For oral contraceptives, official guidance advises switching to a non-oral method or adding barrier contraception for four weeks after initiation and after each dose escalation of the GLP-1 agonist. Specific timing rules apply to certain agonists, requiring Fenza to be taken well before the injection.
Ulipristal Acetate (UPA) Emergency Contraception UPA may interfere with the action of Fenza. Official instructions specify that Fenza or any progestogen-only method should not be started until five days after UPA-EC administration to prevent interference, with barrier methods required during this period.

Co-administration with other medicines that are substrates for the same enzymes may also result in changes to the exposure of the co-administered drug, potentially requiring adjustments for drugs with narrow therapeutic indices.

Mechanism of Action

Direct Disruption of Microbial Cell Integrity

This mechanism is driven by the antifungal compound, Fenticonazole, which functions as an enzyme inhibitor by targeting Lanosterol 14alpha-demethylase within the microbial cell. Blocking this enzyme prevents the synthesis of ergosterol, a core structural element of the fungal cell membrane, leading to the structural failure of the pathogen. Furthermore, Fenticonazole exhibits a broader mechanistic profile by inhibiting microbial virulence factors (like SAP) and disrupting the metabolism of select co-existing bacteria and protozoa, resulting in pathogen cell death and structural degradation.

Cofactor Provision and Host Cellular Mechanism Modulation

Fenza operates through a complementary mechanistic domain involving the comprehensive Micronutrient Complex, which acts via a cofactor-provision mechanism on the host. Ingredients like Zinc, B-vitamins, and Omega-3 fatty acids provide essential cofactors and metabolic substrates necessary for accelerated cellular turnover and energy production. This action provides cofactors necessary for host physiological mechanisms of tissue repair and influences metabolic processes required for epithelial barrier formation and local immune response dynamics.

Dosage and Administration Information

Fenza (fenticonazole) is a vaginal antifungal medication typically available as a vaginal capsule or pessary for vulvovaginal candidiasis.

Administration Guidelines

The medicine is inserted into the vagina, usually as a single dose or a short course of treatment, as directed by a healthcare provider. The recommended time for administration is at night, before going to bed. Lying down immediately following insertion helps to minimize leakage and maximize the drug's contact with the vaginal wall. The vaginal capsule or pessary must not be swallowed.

Step Instruction Detail
1. Preparation Wash your hands thoroughly before and after handling the medication. Ensure the area is clean.
2. Insertion Insert the capsule or pessary high into the vagina. This is generally performed by using the supplied applicator or a clean finger, while positioned on your back with knees bent or standing with one foot elevated.
3. Post-Insertion Remain lying down for at least 15 minutes after insertion to allow the medication to dissolve and be absorbed. Use a sanitary pad, not a tampon, to manage any discharge or leakage, as tampons may absorb the medication and reduce its effectiveness.

Important Considerations

  • Sexual Intercourse: Avoid vaginal intercourse during treatment, as it may worsen the condition and there is a risk of infecting a partner. Additionally, components of the medication may damage the latex in condoms and diaphragms, rendering these contraceptives ineffective.
  • Menstruation: Treatment may generally continue during menstruation; however, always use sanitary pads instead of tampons. Consult a doctor if you have concerns regarding use during your period.

Recent Clinical Evidence

Research evidence / Overview of studies for Fenza

Evidence for the Use of Fenza in Acute Vulvovaginal Candidiasis (VVC)

Research exploring Fenza primarily focuses on the Fenticonazole component, and studies for this component examined acute episodes of vaginal yeast infection. Studies exploring short-term symptom changes were conducted, often using Randomized Controlled Trials (RCTs) and comparative trials. These studies were evaluated in adult, non-pregnant women with a confirmed diagnosis of the infection. The research examined how symptoms change over time (such as irritation and burning) and the mycological status (the presence or absence of the Candida species post-treatment).

However, research so far indicates that the evidence is limited when evaluating the full, fixed-dose combination product—Fenticonazole plus the nutritional supplement complex (vitamins, minerals, and fatty acids)—against Fenticonazole used alone. Data are still emerging for this specific combination, and the role of the added micronutrients is still uncertain in relation to clinical or mycological outcomes for VVC.

Research for Fenza in Mixed Vaginal Infections

Research was also conducted in observational settings evaluating daily-life functioning in women dealing with mixed vaginal infections. In vitro (laboratory) studies were used in research exploring potential activity against non-fungal pathogens; clinical studies were used in research exploring short-term symptom changes. Findings indicate that the Fenticonazole component was observed in some studies to be associated with changes in symptom patterns in this context.

Evidence Gaps and Areas of Scientific Uncertainty

The research on Fenza contributes to the broader evidence landscape, but some key limitations exist. Primarily, there is a recognized lack of comparative evidence directly evaluating the specific fixed-dose Fenticonazole and micronutrient combination (Fenza) against the drug component alone. This means that certainty is limited regarding the measurable effect of the added nutritional support in the VVC treatment context. Furthermore, long-term effects are not fully established, as follow-up durations were limited in the main Fenticonazole studies.

Key Studies & References

  1. Micronutrient Supplementation for Adult Health: A Systematic Review and Meta-analysis of Randomized Trials

Frequently Asked Questions (FAQ)

Common questions about Fenza (FAQ)


Q: How long do I usually need to take Fenza for?

Official product information indicates that Fenza (fenticonazole) is typically prescribed as a short course of treatment for vulvovaginal candidiasis. This is generally a short course over multiple days or a single application. The exact duration and product strength are determined by a healthcare professional.


Q: What happens if I miss a dose of Fenza?

If a dose is missed, official guidance suggests avoiding a double dose to make up for a forgotten application. Patients should instead typically continue with their regular schedule for the remaining treatment or follow the specific instructions from a healthcare provider.


Q: Can older adults safely use Fenza?

Regulatory information indicates that use of Fenza in older adults is generally permitted, as official drug documentation does not typically list a specific age-related caution for this group, unlike the restriction for pre-pubertal children. Consultation with a healthcare professional is always advised, particularly if there are pre-existing health conditions.


Q: Does Fenza interact with alcohol?

For the topical, vaginal application of Fenticonazole, regulatory documents generally state that interaction with alcohol is unknown due to low systemic absorption. However, some warnings regarding consumption during antifungal treatment may be provided to minimize potential risks. Patients should consult their product’s specific leaflet.


Q: Is it normal to feel slightly nauseous when first starting Fenza?

Nausea is a recognized systemic side effect associated with the class of azole antifungal agents. Although Fenza is often used locally, regulatory labels include nausea as a possible adverse event, meaning it is a possible side effect that some patients may experience.


Q: Is it true that Fenza can cause a dry mouth?

Dry mouth is not listed as a common side effect for topical Fenticonazole. However, due to the potential for the medication to have minor effects on the central nervous system (CNS), dry mouth is considered a plausible side effect due to the drug class, though it is not frequently cited for the topical application.


Q: What happens if Fenza is taken past its expiration date?

Regulatory guidance strictly advises against using the medicine after the expiry date printed on the packaging. Using expired medication cannot guarantee the stability, potency, or safety of the product.


Q: Is Fenza available as a generic medicine?

Fenza is a brand name for a combination product. The active antifungal ingredient, Fenticonazole, may be available from other manufacturers as a generic equivalent or under different brand names, depending on the regulatory approvals in your specific location.


Q: How soon after stopping Fenza will the drug be completely out of my system?

Regulatory information documents the half-life of Fenticonazole, which indicates how long the substance remains in the body. After vaginal application, the systemic absorption is low, and the drug is generally eliminated relatively quickly.


Q: Are there different strengths of Fenza available?

Official documentation confirms that the Fenticonazole component of Fenza is available in different strengths for vaginal use. These varying strengths are available for a healthcare provider to determine the appropriate regimen.


Q: Can Fenza cause headaches?

Headache is listed in regulatory documentation as a possible adverse reaction associated with the use of Fenza. It is a known systemic effect that may occur in some individuals using the medication.


Q: Why is consistent timing important when taking Fenza?

The official recommendation to insert the medication at night before going to bed is based on regulatory studies. This timing is advised to maximize the retention of the product at the site of infection and ensure the drug has sufficient contact time to act effectively.


Q: Does Fenza have a risk of dependence or addiction?

Official regulatory documents related to abuse and dependence do not classify antifungal agents like Fenticonazole as substances with abuse potential. Therefore, dependence or addiction is not a reported risk associated with Fenza.


Q: Can Fenza make you feel tired or drowsy?

While systemic effects are generally low, the regulatory label recognizes that the medication can be associated with central nervous system (CNS) effects. This can include symptoms such as dizziness or fatigue, meaning tiredness is a possible side effect that may be experienced.


Q: How common is [specific common side effect, e.g., dizziness] with Fenza?

Regulatory documents classify all reported side effects, including symptoms like dizziness, by their frequency (e.g., common, uncommon, very rare). This classification provides a measured indication of how often a specific symptom is expected to occur in the patient population.


Q: Is Fenza a prescription-only medication?

Fenticonazole's regulatory status varies by country and strength. In some regions, it is a prescription-only medicine, while in others, lower strengths may be available over the counter, requiring consultation with a pharmacist.


Q: What should I do if I accidentally take two doses of Fenza?

Regulatory guidance on accidental overdose recommends contacting a healthcare provider or seeking immediate medical attention, particularly if a vaginal capsule is accidentally swallowed instead of being inserted.


Q: Does Fenza interact with hormonal birth control?

Official labeling explicitly warns that the oily excipients in Fenticonazole can damage latex barrier contraceptives, such as condoms and diaphragms, rendering them ineffective. Patients are advised to consult a healthcare professional regarding any potential interactions with oral hormonal contraceptives, as specific guidance may be necessary.


Q: Are there any specific lifestyle changes recommended while taking Fenza?

Regulatory documents recommend avoiding vaginal intercourse during the course of treatment. They also advise using sanitary pads instead of tampons, as tampons may absorb the medication and reduce its effectiveness.


Q: What information should I share with my doctor before starting Fenza?

Patients should inform their doctor of any pre-existing medical conditions, such as known hypersensitivity or hemochromatosis, and provide a comprehensive list of concurrent medications, particularly any enzyme inducers or hormonal contraceptives, to ensure safe use.


Q: Can Fenza make you more sensitive to the sun?

Photosensitivity, or increased sensitivity to the sun, is a known risk for some drugs in the azole antifungal class. While it is not a common side effect for topical Fenticonazole, it is a recognized, potential adverse reaction listed in some official documentation.


Q: What is the typical time frame for seeing the full effect of Fenza?

Regulatory-cited clinical studies indicate that patients may begin to see relief of symptoms within a few days of starting treatment. The full therapeutic effect is typically assessed after the patient has completed the prescribed short course of medication.


Q: Are there any known drug-disease interactions for Fenza?

Official warnings and contraindications address specific drug-disease interactions. For example, the product is strictly contraindicated for individuals with a known hypersensitivity. For the systemic component containing iron, caution is advised for patients with hemochromatosis due to the risk of Iron Overload Syndrome.


Q: Can Fenza be crushed or split?

The medication is supplied as a vaginal capsule (ovule) or pessary for insertion into the vagina. Regulatory administration instructions do not permit crushing, chewing, or otherwise altering the form, as this would compromise the intended local delivery and effectiveness.


Q: Can Fenza be used by people with liver problems?

Systemic azole antifungals can affect the liver. While the vaginal use of Fenticonazole results in low systemic absorption, the use of azoles in patients with pre-existing liver issues may require monitoring by a healthcare professional.


Q: Can Fenza be used by people with kidney issues?

The drug’s elimination route via the kidneys is documented in regulatory sources. Although topical Fenticonazole has low systemic absorption, any use in cases of severe renal impairment (kidney issues) may require management and monitoring by a physician.

How should Fenza be stored and disposed of?

Storage and Disposal Conditions for Fenza

Fenza must be stored under specific environmental controls as mandated by official labeling to ensure product stability.

Storage Requirements

Fenza must be stored at a controlled temperature, not exceeding 30 C (86 F), and must not be frozen. The product should be kept in its original, tightly closed container and protected from both light and moisture.

It is a mandatory safety requirement that Fenza be stored out of the sight and reach of children and pets.

Disposal Instructions

Unused or expired Fenza should ideally be discarded via an official drug take-back program. Regulatory guidance prohibits flushing the medicine down the toilet or pouring it into a drain unless specifically instructed. If a take-back option is unavailable, the product must be mixed with an undesirable substance (e.g., used coffee grounds) and sealed in a container before disposal with household trash. All disposal must comply with local pharmaceutical waste regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Fenza found in:

A-Z Index: